CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 105 filers reported holding CLOVIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $23,000 | -36.1% | 19,687 | 0.0% | 0.00% | – |
Q2 2022 | $36,000 | -18.2% | 19,687 | -10.0% | 0.00% | – |
Q1 2022 | $44,000 | -25.4% | 21,879 | +2.2% | 0.00% | – |
Q4 2021 | $59,000 | -42.7% | 21,413 | -6.5% | 0.00% | – |
Q3 2021 | $103,000 | -10.4% | 22,897 | +15.2% | 0.00% | – |
Q2 2021 | $115,000 | -19.6% | 19,871 | -2.5% | 0.00% | – |
Q1 2021 | $143,000 | +4.4% | 20,383 | -28.4% | 0.00% | – |
Q4 2020 | $137,000 | +3.0% | 28,483 | +24.4% | 0.00% | – |
Q3 2020 | $133,000 | -21.8% | 22,903 | -8.8% | 0.00% | – |
Q2 2020 | $170,000 | +8.3% | 25,101 | +1.6% | 0.00% | – |
Q1 2020 | $157,000 | -38.7% | 24,699 | +0.8% | 0.00% | -100.0% |
Q4 2019 | $256,000 | +1180.0% | 24,500 | +390.0% | 0.00% | – |
Q3 2019 | $20,000 | -87.8% | 5,000 | -54.5% | 0.00% | – |
Q2 2019 | $164,000 | -25.1% | 10,991 | +24.6% | 0.00% | -100.0% |
Q1 2019 | $219,000 | +50.0% | 8,820 | +8.4% | 0.00% | – |
Q4 2018 | $146,000 | -18.0% | 8,139 | +34.2% | 0.00% | -100.0% |
Q3 2018 | $178,000 | -26.7% | 6,064 | +13.2% | 0.00% | 0.0% |
Q2 2018 | $243,000 | -17.9% | 5,355 | -4.2% | 0.00% | 0.0% |
Q1 2018 | $296,000 | +622.0% | 5,589 | +819.2% | 0.00% | – |
Q4 2017 | $41,000 | +20.6% | 608 | +47.2% | 0.00% | – |
Q3 2017 | $34,000 | +325.0% | 413 | +339.4% | 0.00% | – |
Q2 2017 | $8,000 | +100.0% | 94 | +54.1% | 0.00% | – |
Q1 2017 | $4,000 | -89.2% | 61 | -94.2% | 0.00% | – |
Q4 2015 | $37,000 | -47.9% | 1,059 | +37.5% | 0.00% | – |
Q3 2015 | $71,000 | -47.0% | 770 | -49.8% | 0.00% | -100.0% |
Q2 2015 | $134,000 | +22.9% | 1,534 | +4.5% | 0.00% | – |
Q1 2015 | $109,000 | +41.6% | 1,468 | +6.7% | 0.00% | – |
Q4 2014 | $77,000 | +71.1% | 1,376 | +40.0% | 0.00% | – |
Q3 2014 | $45,000 | – | 983 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |